- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticles in Targeted Alpha Therapy
Authors
Keywords
-
Journal
Nanomaterials
Volume 10, Issue 7, Pages 1366
Publisher
MDPI AG
Online
2020-07-14
DOI
10.3390/nano10071366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanohydroxyapatite and its textures as potential carriers of promising short-lived lead isotopes
- (2020) A. V. Severin et al. RUSSIAN CHEMICAL BULLETIN
- A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225
- (2020) Evangelia-Alexandra Salvanou et al. Pharmaceutics
- An experimental study of sorption/desorption of selected radionuclides on carbon nanomaterials: a quest for possible applications in future nuclear medicine
- (2020) Andrey G. Kazakov et al. DIAMOND AND RELATED MATERIALS
- Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
- (2020) Nastassja Terraneo et al. Frontiers in Oncology
- Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy
- (2020) Falco Reissig et al. ChemistryOpen
- Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials
- (2019) Jongho Jeon INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Radiochemical aspects of alpha emitting radionuclides for medical application
- (2019) Maryline G. Ferrier et al. RADIOCHIMICA ACTA
- Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
- (2019) Łucja Dziawer et al. Nanomaterials
- Gadolinium vanadate nanocrystals as carriers of α-emitters (225Ac, 227Th) and contrast agents
- (2019) Miguel Toro-González et al. JOURNAL OF APPLIED PHYSICS
- The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier
- (2019) R. M. de Kruijff et al. Scientific Reports
- Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
- (2019) Joseph A. Clara et al. Nature Reviews Clinical Oncology
- Targeted and Nontargeted α-Particle Therapies
- (2018) Michael R. McDevitt et al. Annual Review of Biomedical Engineering
- In vitro evaluation of 225 Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme
- (2018) Agnieszka Majkowska-Pilip et al. Chemical Biology & Drug Design
- Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue
- (2018) Leszek Krolicki et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The therapeutic potential of polymersomes loaded with 225 Ac evaluated in 2D and 3D in vitro glioma models
- (2018) R.M. de Kruijff et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
- (2018) Edyta Cędrowska et al. JOURNAL OF NANOPARTICLE RESEARCH
- Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer
- (2018) Marek Pruszynski et al. MOLECULAR PHARMACEUTICS
- Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators
- (2018) Ján Kozempel et al. MOLECULES
- Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
- (2018) Mehran Makvandi et al. Targeted Oncology
- Liposomes and polymersomes: a comparative review towards cell mimicking
- (2018) Emeline Rideau et al. CHEMICAL SOCIETY REVIEWS
- Radiopharmaceutical enhancement by drug delivery systems: A review
- (2018) Janke Kleynhans et al. JOURNAL OF CONTROLLED RELEASE
- An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions
- (2018) Leila Farzin et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Sorption of 223Ra and 211Pb on modified nanodiamonds for potential application in radiotherapy
- (2018) B. L. Garashchenko et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Targeted Alpha Therapy, an Emerging Class of Cancer Agents
- (2018) et al. JAMA Oncology
- Barium and Radium Complexation with Ethylenediaminetetraacetic Acid in Aqueous Alkaline Sodium Chloride Media
- (2017) Artem V. Matyskin et al. JOURNAL OF SOLUTION CHEMISTRY
- Nanozeolite bioconjugates labeled with 223 Ra for targeted alpha therapy
- (2017) Agata Piotrowska et al. NUCLEAR MEDICINE AND BIOLOGY
- On AunAt clusters as potential astatine carriers
- (2017) Sławomir Ostrowski et al. RSC Advances
- Gold nanoparticle bioconjugates labelled with 211At for targeted alpha therapy
- (2017) L. Dziawer et al. RSC Advances
- Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
- (2017) Jens Ceder et al. Frontiers in Oncology
- Carbon nanotubes exhibit fibrillar pharmacology in primates
- (2017) Simone Alidori et al. PLoS One
- Study of 223Ra uptake mechanism by Fe3O4 nanoparticles: towards new prospective theranostic SPIONs
- (2016) Olga Mokhodoeva et al. JOURNAL OF NANOPARTICLE RESEARCH
- Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer
- (2016) S. Yook et al. JOURNAL OF NUCLEAR MEDICINE
- Hydroxyapatite particles as carriers for 223Ra
- (2016) A. N. Vasiliev et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Sticky Patches on Lipid Nanoparticles Enable the Selective Targeting and Killing of Untargetable Cancer Cells
- (2016) Michelle Sempkowski et al. LANGMUIR
- In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia
- (2016) U. B. Hagemann et al. MOLECULAR CANCER THERAPEUTICS
- 111 In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after intratumoral injection
- (2016) Zhongli Cai et al. NUCLEAR MEDICINE AND BIOLOGY
- Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with 177Lu
- (2016) Zhongli Cai et al. PHARMACEUTICAL RESEARCH
- Silver impregnated nanoparticles of titanium dioxide as carriers for 211At
- (2016) Edyta Cedrowska et al. RADIOCHIMICA ACTA
- Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-Versagen
- (2016) M. E. Autenrieth et al. UROLOGE
- Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-Versagen
- (2016) M. E. Autenrieth et al. UROLOGE
- Encapsulation of -Particle-Emitting 225Ac3+ Ions Within Carbon Nanotubes
- (2015) M. L. Matson et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and characterization of lanthanum phosphate nanoparticles as carriers for 223 Ra and 225 Ra for targeted alpha therapy
- (2015) J.V. Rojas et al. NUCLEAR MEDICINE AND BIOLOGY
- Prospective carriers of 223Ra for targeted alpha particle therapy
- (2014) J. Kozempel et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects
- (2014) Sutapa Barua et al. Nano Today
- Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles
- (2013) G. Wang et al. APPLIED RADIATION AND ISOTOPES
- LnPO4 Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy
- (2013) Mark F. McLaughlin et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- New Treatment Option
- (2013) Patrick M. Colletti CLINICAL NUCLEAR MEDICINE
- An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
- (2013) Zilin Yu et al. CURRENT PHARMACEUTICAL DESIGN
- Functionalized NaA nanozeolites labeled with 224,225Ra for targeted alpha therapy
- (2013) Agata Piotrowska et al. JOURNAL OF NANOPARTICLE RESEARCH
- Anti-Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular -Particle Therapy of Cancer
- (2013) A. Bandekar et al. JOURNAL OF NUCLEAR MEDICINE
- Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery
- (2013) J. Justin Mulvey et al. Nature Nanotechnology
- Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy
- (2013) Mark F. McLaughlin et al. PLoS One
- Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals construction
- (2013) Marta de Souza Albernaz et al. Artificial Cells Nanomedicine and Biotechnology
- Multifunctional nanocarriers
- (2012) Vladimir P. Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Molecular Pathways: Targeted -Particle Radiation Therapy
- (2012) K. E. Baidoo et al. CLINICAL CANCER RESEARCH
- Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis
- (2012) Markus Essler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cancer and Radiation Therapy: Current Advances and Future Directions
- (2012) Rajamanickam Baskar et al. International Journal of Medical Sciences
- Role of Antibody-Mediated Tumor Targeting and Route of Administration in Nanoparticle Tumor Accumulation in Vivo
- (2012) Niladri Chattopadhyay et al. MOLECULAR PHARMACEUTICS
- LaPO4Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter Radionuclides
- (2011) Jonathan Woodward et al. BIOCONJUGATE CHEMISTRY
- Breast cancer stem cells: treatment resistance and therapeutic opportunities
- (2011) Fares Al-Ejeh et al. CARCINOGENESIS
- Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
- (2011) Kwon Yong et al. DALTON TRANSACTIONS
- Assessment of an effective quasirelativistic methodology designed to study astatine chemistry in aqueous solution
- (2011) Julie Champion et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody
- (2011) J Schwartz et al. PHYSICS IN MEDICINE AND BIOLOGY
- In vivo212Pb/212Bi generator using indium-DTPA-tagged liposomes
- (2011) A. Le Du et al. RADIOCHIMICA ACTA
- Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
- (2010) D. Cordier et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes
- (2010) Michael McDevitt et al. International Journal of Nanomedicine
- 225Ac Metallofullerene: Toward225Ac Nanogenerator in Fullerene
- (2009) Kazuhiko Akiyama et al. CHEMISTRY LETTERS
- Endoradiotherapy in cancer treatment — Basic concepts and future trends
- (2009) Frederic Zoller et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Intraperitoneal -Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study
- (2009) H. Andersson et al. JOURNAL OF NUCLEAR MEDICINE
- 131I-Tositumomab (Bexxar®) vs. 90Y-Ibritumomab (Zevalin®) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma
- (2009) Andrei Iagaru et al. MOLECULAR IMAGING AND BIOLOGY
- Preparation of Rh[16aneS4-diol]211At and Ir[16aneS4-diol]211At Complexes as Potential Precursors for Astatine Radiopharmaceuticals. Part I: Synthesis
- (2008) Marek Pruszyński et al. BIOCONJUGATE CHEMISTRY
- Enhanced Loading Efficiency and Retention of225Ac in Rigid Liposomes for Potential Targeted Therapy of Micrometastases
- (2008) Min-Yuan Chang et al. BIOCONJUGATE CHEMISTRY
- Preclinical Evaluation of the -Particle Generator Nuclide 225Ac for Somatostatin Receptor Radiotherapy of Neuroendocrine Tumors
- (2008) M. Miederer et al. CLINICAL CANCER RESEARCH
- Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer
- (2008) Sudipta Chakraborty et al. NUCLEAR MEDICINE AND BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started